Search Results
Key highlights in CLL: clinical trial updates & the role of combination therapies and novel BTKis
Clinical trial updates and time-limited therapy in CLL
Highlights from a CLL session: BTKis, personalizing care, novel regimens, & more
Exciting updates in CLL and the importance of immune characterization
Targeted therapy in CLL in 2022 and in the future
Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens
Key clinical trials in CLL at ASH 2020
Crafting the New Treatment Mix in CLL
ASH CLL highlights: ibrutinib-venetoclax combination & undetectable MRD in IGHV-mutated patients
Zanubrutinib plus venetoclax for patients with CLL
Pirtobrutinib in CLL: updates from the BRUIN CLL-321 trial
Using molecular features to determine appropriate treatment strategies for patients with CLL
